Overview
Giuseppina Di Stefano practices practicing medicine in Bologna, Italy.
Her clinical expertise encompasses Pancreatic Cancer, Lactic Acidosis, and Burkitt Lymphoma.
She is actively involved in clinical research, co-authoring 32 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Giuseppina Di Stefano
Is Giuseppina Di Stefano a top-rated expert for Pancreatic Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Giuseppina Di Stefano is classified as an Experienced expert for Pancreatic Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Giuseppina Di Stefano participate in research or clinical trials?
Yes. Giuseppina Di Stefano has published 32 articles and abstracts on conditions like Pancreatic Cancer. You can view a list of Giuseppina Di Stefano's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Burkitt LymphomaMs. Di Stefano isExperienced. Learn about Burkitt Lymphoma.
- Lactic AcidosisMs. Di Stefano isExperienced. Learn about Lactic Acidosis.
- Pancreatic CancerMs. Di Stefano isExperienced. Learn about Pancreatic Cancer.